- Go 6983
-
- $36.00
-
2026-07-14
- CAS:133053-19-7
- Purity: 99.85%
- Supply Ability: 10g
- GO 6983
-
- $9.80
-
2020-01-13
- CAS:133053-19-7
- Min. Order: 1g
- Purity: ≥99%
- Supply Ability: 100kg
|
| | GO 6983 Basic information |
| | GO 6983 Chemical Properties |
| Boiling point | 709.0±60.0 °C(Predicted) | | density | 1.31±0.1 g/cm3(Predicted) | | storage temp. | -20°C | | solubility | DMSO: 20 mg/mL, clear, red | | form | powder | | pka | 8.02±0.60(Predicted) | | color | red | | Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 1 month. | | InChIKey | LLJJDLHGZUOMQP-UHFFFAOYSA-N | | SMILES | COc1ccc2n(CCCN(C)C)cc(C3=C(C(=O)NC3=O)c4c[nH]c5ccccc45)c2c1 |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36 | | WGK Germany | 3 | | HS Code | 2933998090 | | Storage Class | 11 - Combustible Solids |
| | GO 6983 Usage And Synthesis |
| Description | Go-6983 (133053-19-7) potent and pan-specific, ATP-competitive protein kinase C inhibitor. PKC isotype IC50s= 7, 7, 6, 10 and 60 nM for PKC α, β, γ, δ, ζ respectively.1 Suppresses stress induced HSP27 disassociation.2 Maintains rat embryonic stem cell pluripotency.3 Attenuates myocardial ischemia/reperfusion injury.4 | | Uses | Go 6983, is a protein kinase C (PKC) inhibitor.Potent PKC Inhibitor | | Uses | GO6983 has been used as a protein kinase C (PKC) inhibitor to study its effects on the nuclear import. It has also been used as a supplement in Fc medium to culture mouse embryonic stem (mES) cells on mitomycin C treated mouse embryonic fibroblasts (MEFs). | | Definition | ChEBI: 3-[1-[3-(dimethylamino)propyl]-5-methoxy-3-indolyl]-4-(1H-indol-3-yl)pyrrole-2,5-dione is a member of indoles and a member of maleimides. | | Biological Activity | Broad spectrum protein kinase C (PKC) inhibitor (IC 50 values are 7, 7, 6, 10, 60 and 20000 nM for PKC α , PKC β , PKC γ , PKC δ , PKC ζ and PKC μ respectively). Displays cardioprotective properties; reduces polymorphonuclear leukocyte adherence and infiltration following myocardial ischemia/reperfusion injury. | | Biochem/physiol Actions | Protein kinase C (PKC) inhibitor that selectively inhibits several PKC isozymes (IC50 = 7 nM for PKCα and PKCβ; 6 nM for PKCγ; 10 nM for PKCδ; and 60 nM for PKCζ), but does not inhibit PKCμ (IC50 = 20 mM). | | storage | -20°C | | References | [1] MICHAEL GSCHWENDT . Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymes[J]. FEBS Letters, 1996, 392 2: Pages 77-80. DOI:10.1016/0014-5793(96)00785-5
[2] KANEFUSA KATO. Protein kinase inhibitors can suppress stress-induced dissociation of Hsp27[J]. Cell Stress & Chaperones, 2001, 18 1: 16-20. DOI:10.1379/1466-1268(2001)006<0016:pkicss>2.0.co;2
[3] GANESHKUMAR RAJENDRAN. Inhibition of protein kinase C signaling maintains rat embryonic stem cell pluripotency.[J]. The Journal of Biological Chemistry, 2013: 24351-24362. DOI:10.1074/jbc.m113.455725
[4] LINDON H. YOUNG Margaret T W Brian J Balin. Gö 6983: A Fast Acting Protein Kinase C Inhibitor that Attenuates Myocardial Ischemia/Reperfusion Injury[J]. Cardiovascular Therapeutics, 2006, 23 3: 255-272. DOI:10.1111/j.1527-3466.2005.tb00170.x |
| | GO 6983 Preparation Products And Raw materials |
|